Study reveals no link between HDL cholesterol and movement disorders
By
HealthDay News
Sep 20, 2024
The findings were seen among adult psychiatric inpatients taking an antipsychotic.
Metformin use tied to lower incidence of death, long COVID after COVID-19
By
HealthDay News
Sep 19, 2024
The incidence of death or postacute sequelae of SARS-CoV-2 was slightly lower with prevalent metformin use.
Diabetes complications tied to higher risk for gum disease
By
HealthDay News
Sep 19, 2024
The presence of dyslipidemia further increases the odds of having gum disease in those with neuropathy and retinopathy.
Cognitively stimulating leisure activity protects from further cognitive decline
By
HealthDay News
Sep 19, 2024
The optimal level of programming is at least three to four times a week in older adults with mild cognitive impairment.
US healthcare system ranks last among wealthy nations, report finds
By
HealthDay News
Sep 19, 2024
People in the United States die the earliest and live the sickest lives out of 10 developed countries, even though the United States spends the most on healthcare, according to the annual report by health...
Senior living operators must adapt to market trends to meet demographic shifts, evolving preferences
By
Kimberly Bonvissuto
Sep 19, 2024
Rebounding occupancy, increasing investment and consolidation activity, and the furthering of integrated healthcare models were among the trends senior living experts discussed during an Argentum webinar.
AARP’s public policy chief talks senior living
Sep 19, 2024
Debra Whitman, executive vice president and chief public policy officer at AARP, discusses her new book, “The Second Fifty: Answers to the 7 Big Questions of Midlife and Beyond,” and the messages it...
The future of senior living: Embracing wellness for a thriving community
By
Elizabeth Audette-Bourdeau
Sep 19, 2024
Those overseeing programming and recreation in senior living must understand the evolving landscape and adapt their strategies to meet the demands of the future.
SGLT2i use linked to lower risk for neurodegenerative disease in T2DM
By
HealthDay News
Sep 18, 2024
A reduced risk for Alzheimer’s disease, vascular dementia and Parkinson’s disease was seen with SGLT2i use in type 2 diabetes.
Caffeine, coffee linked to lower cardiometabolic multimorbidity risk
By
HealthDay News
Sep 18, 2024
Habitual caffeine or coffee intake, especially at moderate levels, was linked to a lower risk for new-onset cardiometabolic multimorbidity, which was defined as the coexistence of at least two of type...